Novel Nitro-Heteroaromatic Antimicrobial Agents for the Control and Eradication of Biofilm-Forming Bacteria

The synthesis and biological activity of several novel nitrothiazole, nitrobenzothiazole, and nitrofuran containing antimicrobial agents for the eradication of biofilm-forming Gram-negative and Gram-positive pathogens is described. Nitazoxanide (NTZ), nitrofurantoin, and furazolidone are commercial...

Full description

Saved in:
Bibliographic Details
Main Authors: Heidi N. Koenig (Author), Gregory M. Durling (Author), Danica J. Walsh (Author), Tom Livinghouse (Author), Philip S. Stewart (Author)
Format: Book
Published: MDPI AG, 2021-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The synthesis and biological activity of several novel nitrothiazole, nitrobenzothiazole, and nitrofuran containing antimicrobial agents for the eradication of biofilm-forming Gram-negative and Gram-positive pathogens is described. Nitazoxanide (NTZ), nitrofurantoin, and furazolidone are commercial antimicrobials which were used as models to show how structural modification improved activity toward planktonic bacteria via minimum inhibitory concentration (MIC) assays and biofilms via minimum biofilm eradication concentration (MBEC) assays. Structure-activity relationship (SAR) studies illustrate the ways in which improvements have been made to the aforementioned antimicrobial agents. It is of particular interest in this regard that the introduction of a chloro substituent at the 5-position of NTZ (analog <b>1b</b>) resulted in marked activity enhancement, as did the replacement of the 2-acetoxy substituent in the latter compound with a basic amine group (analog <b>7b</b>). It is also of importance that analog <b>4a</b>, which is a simple methacrylamide, displayed noteworthy activity against <i>S. epidermidis</i> biofilms. These lead compounds identified to have high activity towards biofilms provide promise as starting points in future pro-drug studies.
Item Description:10.3390/antibiotics10070855
2079-6382